18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. - Vandenberghe, R; Van Laere, K; Ivanoiu, A; Salmon, E; Bastin, C; Triau, E; Hasselbalch, S; Law, I; Andersen, A; Korner, A; Minthon, L; Garraux, G; et al. (Annals of neurology, 2010)